AFT PHARMACEUTICALS LIMITED AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release on Monday May 22 2023 its full year results for the year ended March 31 2023. The release will be issued at around 09:00.
This will be followed by a presentation by management at 10:00 by teleconference. The presentation material which will be referred to by management will be issued at around 09:00 and will also be available on the company's website aftpharm.com.
To attend the conference call you will need to use the pre-registration link below. Once you have completed this you will be provided with dial in details and a unique pin code.
Registration Link: AFT results presentation FY2023
Released for and on behalf of AFT Pharmaceuticals by Malcolm Tubby, Chief Financial Officer.
For more information:
Media:
Richard Inder
The Project
Tel: +64 9488 0232
Investors:
Dr Hartley Atkinson
Managing Director
AFT Pharmaceuticals Tel: +64 21 645 643
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
AFT Pharmaceuticals Limited published this content on 05 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 May 2023 00:12:03 UTC.
